Key Highlights
- ABNB reached a 52-week peak of $187.14, climbing approximately 45% year-over-year
- Second quarter 2026 revenue totaled $3.61 billion, marking a 16.3% annual increase, with earnings per share of $1.37 exceeding forecasts by $0.11
- Wedbush elevated ABNB to Outperform status and boosted its price target to $200
- Wall Street consensus rating stands at “Moderate Buy” with an average price objective of $172
- Company insiders offloaded more than 3.1 million shares valued at nearly $459 million over the last three months, including transactions by CEO Brian Chesky
Shares of Airbnb (ABNB) climbed to a 52-week peak of $187.14 on Tuesday, hovering around $187.35 with a total market valuation of $109.5 billion. The rental platform’s equity has appreciated roughly 45% over the trailing twelve months.
The rally comes on the heels of impressive second quarter 2026 financial results. The company posted revenue of $3.61 billion, representing a 16.3% jump from the prior year and narrowly surpassing the Wall Street estimate of $3.58 billion. Earnings per share reached $1.37, topping the consensus forecast of $1.26 by eleven cents.
The company’s adjusted EBITDA similarly exceeded projections, coming in 2.7% above analyst expectations. Airbnb’s third quarter 2026 revenue outlook, with a midpoint of $4.73 billion, also surpassed Street forecasts by an identical margin.
The rental platform maintains an impressive gross profit margin of 82.9%, a metric that has garnered significant analyst attention. Additionally, the company operates with a conservative debt-to-equity ratio of 0.32.
Wall Street Upgrades and Target Increases
Wedbush emerged as one of the most optimistic voices, elevating ABNB from Neutral to Outperform while pushing its price objective to $200. The investment firm highlighted platform enhancements and solid financial performance as primary catalysts.
Susquehanna increased its price objective from $170 to $200, maintaining a “positive” outlook on the shares. Jefferies adjusted its target upward from $160 to $175 alongside a “buy” recommendation. Raymond James shifted from market perform to strong buy in May.
UBS elevated its target to $172 while maintaining a Neutral stance, pointing to product enhancements and accelerating growth in nights booked. Bernstein maintained its Outperform view with a $168 price objective.
However, not all analysts share the enthusiasm. Phillip Securities downgraded ABNB to Reduce, expressing concerns about elevated valuation multiples despite raising its own target to $158. Truist maintained a “hold” position with a $134 price objective.
The aggregate view from 39 Wall Street analysts is “Moderate Buy” with a mean price target of $172.
Significant Insider Transactions Raise Questions
While analysts have grown increasingly bullish, insider transaction data paints a contrasting picture. During the past three months, company insiders have divested more than 3.1 million shares valued at approximately $459 million.
Chief Executive Brian Chesky offloaded 20,000 shares on August 7 at a mean price of $173.61, generating proceeds of $3.47 million. This transaction decreased his direct stake by 77.36%.
Nathan Blecharczyk, another company insider, sold 531,000 shares on the identical date at an average of $174.41, with the transaction valued at more than $92.6 million. This sale reduced his holdings by 75.60%.
Meanwhile, institutional investors have been accumulating shares. HS Management Partners established a fresh position comprising 67,186 shares valued at approximately $9.6 million during the second quarter. Institutional ownership currently represents 80.76% of shares available for trading.
Wall Street projects full-year earnings per share of $5.22 for the current fiscal period. The stock’s 50-day moving average is positioned at $150.83, while the 200-day moving average sits at $138.38.





